Arindam Sharma, MD
Advanced Heart Failure and Transplant Cardiology · Rochester, MNNPI 1700237385
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,570 of the $1,911 with a category attached, or 82.1%. Abbott accounts for 74.1% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $1,016 and has fallen 84.1% since, to $162 in 2025.
Across 31 payments — averaging $61.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$1K
- Abiomed$175
- Amgen$115
- Boston Scientific$99
- Pfizer$42
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$34
- plus $28 from 2 others
What the payments were for
- Travel & lodging$34218%
- Food & beverage$1,57082%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 18 | $1,417 |
| Abiomed | 3 | $175 |
| Amgen | 1 | $115 |
| Boston Scientific | 2 | $99 |
| Pfizer | 3 | $42 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $34 |
| Novartis | 1 | $14 |
| Impulse Dynamics (USA) Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENSITE PRECISION$594
- CentriMag$171
- CARDIOMEMS$162
- HeartMate 3 Left Ventricular Assist Device$143
- Repatha$115
- Impella$104
How this compares
$1,911 in reported general payments places this provider in the 55th percentile of 32 advanced heart failure and transplant cardiology providers in Minnesota.
See all advanced heart failure and transplant cardiology providers in Minnesota →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Digoxin | 20 | $1,886 |
| Metoprolol Succinate | 50 | $577 |
| Spironolactone | 46 | $422 |
| Carvedilol | 20 | $295 |
| Torsemide | 16 | $264 |
| Lisinopril | 34 | $235 |
| Atorvastatin Calcium | 11 | $111 |
Paid to pharmacies, not to this prescriber.
Other advanced heart failure and transplant cardiology in Rochester
- Barry BorlaugRochester$173K
- Robert FrantzRochester$141K
- Omar AbouezzeddineRochester$10K
- Swaiman SinghRochester$9K
- Dipan UppalRochester$4K
- Naveen PereiraRochester$3K
- Farris TimimiRochester$3K
- Rosalyn AdigunRochester$2K
- Atta BehfarRochester$2K
- Alfredo ClavellRochester$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.